Skip to content

Stryker closes Israel operations > Sightline Technologies > Innovative medical device > No commercializing and further development > ColonoSight system > Colonoscope with a disposable ColonoSleeve tube and sheath > Diagnosing and treating abnormalities > Large intestine > Intellectual property > EndoSight non-fiber optic colonoscope > Disposable ColonoSleeve multi-lumen tube > Covered by a compressed protective sheath > Electro-pneumatic System Control Unit SCU > Advanced IntraPull power-assisted disposable technology > Improves safety and speed > Protective sheath > Places disposable barrier > Gastroenterologists > Reducing risk of infection > Risk of intestinal perforation

Did Stryker Israel succeed in developing its flagship colonoscopy product to a commercial level? Was Sightline’s ColonoSight system already FDA-cleared for the U.S. market? What is the result of the pre-marketing clinical study to further validate the ColonoSight cost effectiveness?

colonoscopy.jpg

IIP > read on here > http://www.globes.co.il…

All 71 employees of the medical device development company have been fired.

Stryker Corp. is closing down its Israel operations. Endoscopic solution developer Stryker Israel, formerly known as SightLine Technologies, is firing all 71 employees. A statement issued by Stryker in the US said “Problems in product design alongside the economic crisis have contributed to this decision.”

Stryker Israel has not succeeded in developing its flagship colonoscopy product to a commercial level. In better economic times the US corporation, which acquired SightLine in 2006 for $150 million, might have considered investing additional capital in the project. Forty five employees developing the colonoscopy project will lose their jobs, while an additional 26 employees working on gastroenterology projects, which is also being closed down, will also be fired.